Bulletin
Investor Alert

New York Markets Open in:

Alexion Pharmaceuticals Inc.

NAS: ALXN

GO
/marketstate/country/us

After Hours

/zigman2/quotes/206262068/composite

$

118.00

Change

-0.19 -0.16%

Volume

Volume 242,667

Oct 21, 2020, 7:47 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/206262068/composite

Previous close

$ 124.00

$ 118.19

Change

-5.81 -4.69%

Day low

Day high

$118.18

$123.72

Open
Open: 123.72

52 week low

52 week high

$72.67

$128.57

Open

Market cap

$27.18B

Average volume

2.23M

P/E ratio

31.59

Rev. per Employee

$1.56M

EPS

3.74

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/alxn

MarketWatch News on ALXN

  1. Buying the Most-Profitable Companies Seems Simple

    9:14 a.m. Oct. 13, 2020

    - Barron's Online

  2. U.S. Stocks Rebound on Hope for Targeted Stimulus

    4:43 p.m. Oct. 7, 2020

    - Barron's Online

  3. Alexion Says Promising New Drugs Will Boost Growth

    6:19 p.m. Oct. 6, 2020

    - Barron's Online

  4. Alexion expects to return $3 bln to shareholders through 2023

    6:35 a.m. Oct. 6, 2020

    - Tomi Kilgore

  5. Alexion Pharmaceuticals expects to raise 2020 revenue outlook by more than $200 mln

    6:35 a.m. Oct. 6, 2020

    - Tomi Kilgore

  6. Stocks Close Mixed as Record Month Comes to a Close

    4:50 p.m. Aug. 31, 2020

    - Barron's Online

  7. 5 Biopharma Stocks That Are Affordable And Growing

    12:56 p.m. July 17, 2020

    - Barron's Online

  8. Alexion Needs to Ditch Its Acquisitions Strategy, Analyst Writes

    1:11 p.m. July 14, 2020

    - Barron's Online

  9. Alexion to pay $21 million to resolve SEC charges

    9:12 a.m. July 2, 2020

    - Jaimy Lee

  10. SEC says Alexion Russia made improper payments to Russian govt officials

    8:52 a.m. July 2, 2020

    - Ciara Linnane

  11. SEC says Alexion units in Brazil and Colombia failed to keep accurate books and records

    8:53 a.m. July 2, 2020

    - Ciara Linnane

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/alxn

Other News on ALXN

  1. Plenty More Upside To See In Alexion Pharmaceuticals In 2020

    11:07 a.m. Oct. 21, 2020

    - Seeking Alpha

  2. 7 Large Biotechs Expected to Outperform This Earnings Season

    8:30 a.m. Oct. 17, 2020

    - 247WallSt.com

  3. Alexion's Ultomiris Gets FDA Approval for New Formulation

    10:30 a.m. Oct. 13, 2020

    - Zacks.com

  4. Argenx: Competitive Positioning In The GMG Space

    5:15 a.m. Oct. 13, 2020

    - Seeking Alpha

  5. Short Sellers Need to Find a Clue on Major Biotechs

    9:34 a.m. Oct. 12, 2020

    - 247WallSt.com

  6. New formulation of Alexion's Ultomiris Ok'd by FDA

    8:58 a.m. Oct. 12, 2020

    - Seeking Alpha

  7. Wall Street Breakfast: The Week Ahead

    10:16 a.m. Oct. 11, 2020

    - Seeking Alpha

  8. Stocks To Watch: Amazon, Apple, Zoom And Stimulus Drama

    8:45 a.m. Oct. 10, 2020

    - Seeking Alpha

  9. 4 Very Profitable Biotech Stocks Expected to Soar Into 2021

    11:32 a.m. Oct. 9, 2020

    - 247WallSt.com

  10. Alexion Pharmaceuticals bid up on PE chatter

    11:26 a.m. Oct. 9, 2020

    - Seeking Alpha

  11. Stock Market News for Oct 8, 2020

    9:29 a.m. Oct. 8, 2020

    - Zacks.com

  12. Alexion (ALXN) in Focus: Stock Moves 7.9% Higher

    8:37 a.m. Oct. 8, 2020

    - Zacks.com

  13. Loading more headlines...
/news/pressrelease/company/us/alxn

Press Releases on ALXN

  1. Charles River Laboratories Adds George Llado to Board of Directors

    9:15 a.m. Oct. 16, 2020

    - BusinessWire - BZX

  2. Nasdaq 100 Movers: EBAY, PDD

    10:29 a.m. Oct. 12, 2020

    - MarketNewsVideo.com

  3. Soliris Market Competitive Analysis, Demand and Growth Outlook 2020 to 2025

    2:53 a.m. Oct. 9, 2020

    - Market Insight Reports

  4. Thursday's ETF Movers: ILF, BBH

    12:12 p.m. Oct. 8, 2020

    - MarketNewsVideo.com

  5. Loading more headlines...

Rates »

Link to MarketWatch's Slice.